Nara Organics recalls baby formula sold at Target after multistate infant botulism outbreak

In late June 2026, Nara Organics issued a voluntary recall of its Whole Milk Organic Powdered Infant Formula following reports of a multistate outbreak of infant botulism. Federal agencies, including the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), confirmed that three infants had fallen ill after consuming the product. These cases spanned three states—California, Pennsylvania, and Washington—and involved babies aged between two and five months. Each of the affected infants was hospitalized and received treatment with BabyBIG, an intravenous antitoxin derived from the plasma of individuals immunized against botulism. No fatalities were reported, but the incident has raised significant concerns about the safety of infant formula, particularly those marketed as organic or premium alternatives.

The outbreak began in April and May 2026, with the affected infants having consumed the Nara Organics formula during that time period. The product was sold nationwide through Target stores, Target.com, and directly via Nara's website, Nara.com. The formula, which is produced in Europe and exclusively distributed in the United States, accounted for less than 1% of the total infant formula market in the country. Despite the recall, the FDA emphasized that the situation would not lead to a shortage of infant formula, alleviating some of the fears among parents and caregivers. However, the incident has prompted renewed scrutiny of the safety protocols surrounding infant formula manufacturing and distribution.

The CDC and FDA have issued detailed guidance to parents and caregivers who may have purchased the recalled formula. Consumers are instructed to cease using the product immediately and to store any remaining containers safely, labeling them "DO NOT USE" and keeping them separate from other baby food items. Those who have opened the formula are encouraged to document the lot numbers and expiration dates and to monitor their infants for symptoms such as constipation, poor feeding, drooping eyelids, weak muscle tone, difficulty swallowing, and breathing issues. If no symptoms arise within a month, the unused formula should be discarded. Health officials have also warned that the symptoms of infant botulism can take several weeks to manifest, underscoring the importance of vigilance and prompt medical intervention if signs of illness appear.

Nara Organics expressed deep concern over the situation and stated that the company acted in an "abundance of caution" to ensure the safety of infants. The firm emphasized that protecting the health of babies was its top priority and that it was cooperating fully with regulatory investigations. Meanwhile, the FDA is conducting an ongoing inquiry into the source of the contamination, examining the production process, supply chain, and raw materials used in the formulation of the product. While no specific findings have yet been disclosed, the agency has indicated that it is collaborating with international partners to better understand the risks posed by *Clostridium botulinum* in infant formula and to implement improved monitoring strategies.

This latest incident echoes a previous outbreak linked to ByHeart's Whole Nutrition Infant Formula in late 2025, which resulted in approximately 48 cases of infant botulism across 17 states. At the time, the FDA launched a comprehensive investigation into the contamination, which remains active as of early 2026. The recurrence of such incidents has sparked discussions among public health experts and consumer advocates regarding the adequacy of current safety standards for infant formula. Some critics argue that the marketing of certain premium and organic formulas may mislead parents into believing these products are inherently safer, despite the lack of scientific evidence supporting such claims.

Experts stress that while infant formula is generally considered safe, the consequences of contamination can be severe. Dr. Steven Abrams, a pediatrician specializing in nutrition, noted that the composition of most infant formulas is highly regulated and standardized, requiring the inclusion of 30 essential nutrients. He cautioned that additional features such as organic certification or the presence of probiotics do not necessarily confer greater safety benefits. Similarly, Frank Yiannas, a former FDA official, highlighted the need for stringent oversight in the reformulation of powdered infant formula, emphasizing that the recent outbreaks involving Nara Organics and ByHeart underscore the critical importance of rigorous quality control measures.

As the investigation into the Nara Organics recall continues, the focus will remain on identifying the exact cause of the contamination and implementing preventive measures to avoid similar incidents in the future. For now, parents and caregivers are advised to follow the guidance of health authorities, exercise caution with infant formula consumption, and stay informed about any updates related to product recalls or safety advisories.